128 related articles for article (PubMed ID: 2155674)
1. Inositol-1-phosphatase in red blood cells of manic-depressive patients before and during treatment with lithium.
Moscovich DG; Belmaker RH; Agam G; Livne A
Biol Psychiatry; 1990 Mar; 27(5):552-5. PubMed ID: 2155674
[No Abstract] [Full Text] [Related]
2. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
Kaya N; Resmi H; Ozerdem A; Guner G; Tunca Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):521-7. PubMed ID: 15093960
[TBL] [Abstract][Full Text] [Related]
3. Inositol-1-phosphatase of human erythrocytes is inhibited by therapeutic lithium concentrations.
Agam G; Livne A
Psychiatry Res; 1989 Feb; 27(2):217-24. PubMed ID: 2540502
[TBL] [Abstract][Full Text] [Related]
4. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.
Steen VM; Løvlie R; Osher Y; Belmaker RH; Berle JO; Gulbrandsen AK
Pharmacogenetics; 1998 Jun; 8(3):259-68. PubMed ID: 9682271
[TBL] [Abstract][Full Text] [Related]
5. Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness.
Steen VM; Gulbrandsen AK; Eiken HG; Berle JO
Pharmacogenetics; 1996 Feb; 6(1):113-6. PubMed ID: 8845858
[No Abstract] [Full Text] [Related]
6. Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression.
Kofman O; Belmaker RH
Biol Psychiatry; 1993 Dec; 34(12):839-52. PubMed ID: 8110911
[TBL] [Abstract][Full Text] [Related]
7. Prediction of clinical course of bipolar manic depressive illness treated with lithium.
Johnston BB; Naylor GJ; Dick EG; Hopwood SE; Dick DA
Psychol Med; 1980 May; 10(2):329-34. PubMed ID: 6247737
[TBL] [Abstract][Full Text] [Related]
8. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy.
Shamir A; Ebstein RP; Nemanov L; Zohar A; Belmaker RH; Agam G
Mol Psychiatry; 1998 Nov; 3(6):481-2. PubMed ID: 9857972
[No Abstract] [Full Text] [Related]
9. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
Atack JR; Broughton HB; Pollack SJ
Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
[TBL] [Abstract][Full Text] [Related]
10. A safe lithium mimetic for bipolar disorder.
Singh N; Halliday AC; Thomas JM; Kuznetsova OV; Baldwin R; Woon EC; Aley PK; Antoniadou I; Sharp T; Vasudevan SR; Churchill GC
Nat Commun; 2013; 4():1332. PubMed ID: 23299882
[TBL] [Abstract][Full Text] [Related]
11. The effect of haloperidol on serum levels of lithium in adult manic patients.
Schaffer CB; Batra K; Garvey MJ; Mungas DM; Schaffer LC
Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
[No Abstract] [Full Text] [Related]
12. Combined haloperidol and lithium carbonate in treating manic patients.
Krishna NR; Taylor MA; Abrams R
Compr Psychiatry; 1978; 19(2):119-20. PubMed ID: 630853
[No Abstract] [Full Text] [Related]
13. [A comparative evaluation of the effect of lithium carbonate, haloperidol and preparation IB-503 in the treatment of manic states].
Nuller IuL; Rabinovich MM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(2):277-83. PubMed ID: 5572074
[No Abstract] [Full Text] [Related]
14. Effect of combined haloperidol-lithium treatment on vitro RBC lithium uptake in patients with affective disorders.
Werstiuk ES; Grof P; Rotstein E; Werner L
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):831-4. PubMed ID: 6686715
[TBL] [Abstract][Full Text] [Related]
15. The effect of lithium on red blood cell cholinesterase activity in patients with affective disorders.
Fieve RR; Milstoc M; Kumbaraci T; Dunner DL
Dis Nerv Syst; 1976 May; 37(5):240-3. PubMed ID: 1261342
[No Abstract] [Full Text] [Related]
16. Structure of inositol monophosphatase, the putative target of lithium therapy.
Bone R; Springer JP; Atack JR
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10031-5. PubMed ID: 1332026
[TBL] [Abstract][Full Text] [Related]
17. Possible role of 3'(2')-phosphoadenosine-5'-phosphate phosphatase in the etiology and therapy of bipolar disorder.
Agam G; Shaltiel G
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):723-7. PubMed ID: 12921902
[TBL] [Abstract][Full Text] [Related]
18. Effects of lithium therapy on mao in manic-depressive illness.
Berrettini WH; Vogel WH; Ladman RK
Am J Psychiatry; 1979 Jun; 136(6):836-8. PubMed ID: 443473
[No Abstract] [Full Text] [Related]
19. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
20. Lithium treatment of manic-depressive illness. Past, present, and perspectives.
Schou M
JAMA; 1988 Mar; 259(12):1834-6. PubMed ID: 3278154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
